EN
HI

VENUS REMEDIES Share price

VENUSREM

HealthcareSmall

337.6

0.00 (0.00%)
NSE
BSE
Last updated on 19 May, 2025 | 15:51 IST
BUYSELL
Today's High

350.00

Today's Low

336.30

52 Week Low

270.25

52 Week High

427.90

The current prices are delayed, login to your account for live prices

Venus Remedies Chart

VENUS REMEDIES Share Key Metrics

Volume
27142.00
Market Cap
451.27 CR
LTQ@LTP
1@337.60
ATP
345.61
Var Margin
23.65 %
Circuit Range
270.1-405.1
Delivery %
64.39 %
Value
93.81 L
ASM/GSM
No
Market Lot
1

VENUS REMEDIES Futures & Options

Data Not Found

VENUS REMEDIES Corporate Actions

DateAgenda
2025-02-04Quarterly Results
DateEvent TypeAgenda
2025-02-04Board MeetingQuarterly Results

VENUS REMEDIES News

Venus Remedies gets GMP approval for pre-filled syringe facility

Nov 05 2024 15:21:59
Read More

About VENUS REMEDIES

NSE : 13859  
BSE : 526953  
ISIN : INE411B01019  

M/s VENUS REMEDIES LTD. was incorporated as a privatelimited company on 15th day of Sept. 1989 in the name andstyle of Venus Glucose Pvt Ltd and subsequently convertedinto a public limited company vide fresh certificate ofincorporation dated 19th Sept. 1994 and the name wasconverted as "Venus Remedies Ltd" under the Companies Actissued by the Registrar of Companies Punjab HimachalPradesh and Chandigarh at Jalandhar. The company startedits production in the year 1991 withIntravenous/Intramuscular (IV/IM) injectable forms at itsrunning unit located at 52 Ind. Area. Phase-I PanchkulaDistt. Ambala (Haryana). Subsequently the companyintroduced Eye/Ear/Nasal Drops during the year 1994. Duringthe same year the company also expanded its existingcapacity from 9 lacs pieces per annum to 15 lacs pieces perannum and that of 9 lacs pieces to 20 lacs pieces per annumof IV fluids section and vial section respectively. Andduring 1994 the company has also certified as "WHO-GMP"(Good practices in manufacturing and quality control) asspecified by WHO Geneva by the State Drug Controller ofHaryana.MAIN OBJECTS OF THE COMPANYThe main objects of the company as set out in itsMemorandum of Association are :1. To manufacture import export of intravenous transfusionfluids and formations such as dextrose dextrose withsodium chloride normal saline isolate P isolate Misolate G isolate E Mannitol etc. in variousconcentrations intravenous solution for dialysis purposesACD Sterile bottles for blood collections pharmaceuticalparenteral preparations like AminophyllineAdernaline Water for injection Chloroquine SulphateSodium bi-carbonate Analgin Diazepam Oxyphenbutazone &other injectables.2. To carry on the business of deriving formulatingpurchasing producing manufacturing preparing processingmising compounding refining marketing distributingselling and trading in pharmaceuticals Chemicalscosmetics perfumes medicines and drugs of all kindsspecifications and descriptions and to do so especially inrespect of all kinds of analgesics and antipyretics.3. To carry on the business of purchasing producingmanufacturing preparing processing mixing compoundingrefining marketing distributing selling and trading inall classes and kinds of raw material ingredientsmixtures compounds and derivatives connected tointermediate in or associated with the manufactureproduction and sale of pharmaceuticals chemicals medicinesand drugs.4. To carry on the business of vialling bottling packing.repacking and processing of capsules syrups tabletsinjectables aerosoles and ointment bulk drugs andchemicals.

VENUS REMEDIES Management

NamePosition
Mr. Pawan Chaudhary Chairman & Managing Director
Dr.(Mrs.) Manu Chaudhary Joint Managing Director
Mr. Peeyush Jain Deputy Managing Director
Mr. Ashutosh Jain Executive Director
Mr. Akshansh Chaudhary Executive Director
Read More

VENUS REMEDIES FAQs

The Buying Price of VENUS REMEDIES share is 337.6 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy VENUS REMEDIES share log in to your Choice trading account, or open a Choice Demat account, then add funds, search the company name, select your order type, and place your trade.

The Price-to-earnings (P/E) ratio of VENUS REMEDIES shares is 9.14. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio VENUS REMEDIES shares is 0.84. Useful to assess the stock's value relative to its book value.

To assess VENUS REMEDIES’s valuation compare Sector P/E, P/B which are 41.77 & 4.72 with sector averages, along with growth rates and financial metrics.

The Market Cap of VENUS REMEDIES is 451.27 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of VENUS REMEDIES share price is 427.90 & 270.25. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.